At its annual Worldwide Developers Conference (WWDC), Apple Inc. $AAPL unveiled Liquid Glass, a system-wide user interface redesign that will be implemented across all Apple operating systems. Presented via pre-recorded keynote from Cupertino, California, the update was described by Alan Dye, Apple's VP of Human Interface Design, as the company’s most significant visual revamp to date.

Advent International has submitted a conditional acquisition proposal for Spectris Plc $SXS.L, a leading UK-based producer of precision instrumentation and test software, valuing the company at £3.7 billion (USD 5 billion). The offer, disclosed Monday, prices Spectris shares at £37.63 each, representing an 85% premium to the prior Friday’s closing level.

Metsera Inc. $MTSR, a biotech startup targeting obesity, saw a sharp rally in its stock after releasing positive early-stage trial data for its experimental weight-loss therapy, MET-233i. According to the company, the injectable drug enabled patients to lose up to 8.4% of their body weight within just 36 days during a Phase 1 study — surpassing preliminary expectations. Beyond efficacy, the treatment demonstrated prolonged bioavailability, allowing for a potentially game-changing shift from weekly to monthly administration. That differentiator, if validated in later-stage trials, could directly challenge the current market dominance of weekly injectables such as Wegovy by Novo Nordisk A/S $NVO and Zepbound by Eli Lilly & Co. $LLY.